"This FDA Breakthrough Device Designation underscores the potential of our computational pathology platform to enable more personalised treatment decisions for people with cancer,” said Susan ...

A Finnish study which tracked the health of hundreds over decades shows the importance of tackling poor lifestyle choices ...